Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic Syndrome
Clinical trial NCT02130882 · UNKNOWN
Trial details
- NCT number
- NCT02130882
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-19
- Primary completion
- 2020-06-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.